Effectiveness and Safety of Early Rhythm Control in Patients With Atrial Fibrillation and Chronic Kidney Disease

Atrial Fibrillation

Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry

Clin Res Cardiol

Menichelli D, Gazzaniga G, Poli D, Palareti G, Antonucci E, Pani A, Pignatelli P, Pastori D, START2 Register Investigators

doi: 10.1007/s00392-025-02765-7

Atrial Fibrillation

Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III

J Am Heart Assoc

Corica B, Romiti GF, Proietti M, Mei DA, Boriani G, Olshansky B, Huisman MV, Lip GYH, GLORIA‐AF Investigators

doi: 10.1161/JAHA.125.044293

Atrial FibrillationHeart Failure

Long-Term Effects of Catheter Ablation vs Medical Therapy in Patients with Atrial Fibrillation and Heart Failure: A Reconstructed Individual Patient Data Meta-Analysis

Heart Rhythm

Itaya ED, Aranha F, Barbosa LM, Silva Sanchez GJ, Ternes CMP, d'Avila A

doi: 10.1016/j.hrthm.2026.05.006

Hypertension

Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension

Hypertension

Rossignol P, Clozel M, Dreier RF, Flack JM, Flamion B, Mann J, Narkiewicz K, Sassi-Sayadi M, Wang JG, Weber M, Schlaich M

doi: 10.1161/HYPERTENSIONAHA.125.25563

Atrial Fibrillation

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Heart Rhythm

Boriani G, McIntyre WF, Ramasundarahettige C, Proietti M, Glotzer TV, Diemberger I, Nielsen JC, Essebag V, Granger CB, Sandhu RK, Benezet-Mazuecos J, Mabo P, Coutu B, Wong JA, Gold MR, Lopes RD, Healey JS, ARTESiA Investigators

doi: 10.1016/j.hrthm.2025.07.002

Atrial Fibrillation

Risk of syncope and permanent pacing with rate versus rhythm control of atrial fibrillation: A systematic review and meta-analysis

Heart Rhythm

Quevillon T, Faridi B, McIntyre WF, Betteridge-LeBlanc S, Little S, Michael F, Parkash R, Andrade J, Ha A, Amit G, Healey JS, Ko DT, Shurrab M

doi: 10.1016/j.hrthm.2025.08.014

Atrial FibrillationTherapy and Intervention

Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial

JAMA Cardiol

Patel SM, Giugliano RP, Morrow DA, Goodrich EL, Murphy SA, Hug B, Parkar S, Chen SA, Goodman SG, Joung B, Kiss RG, Wojakowski W, Weitz JI, Bloomfield D, Sabatine MS, Ruff CT

doi: 10.1001/jamacardio.2025.3393

Cardiovascular Risk and Diseases

Safety and efficacy of steroidal mineralocorticoid receptor antagonists in patients with kidney failure requiring dialysis: a systematic review and meta-analysis of randomised controlled trials

Lancet

Pyne L, Rossignol P, Giles C, Junek M, Mark PB, Gallagher M, de Zoysa JR, Devereaux PJ, Walsh M

doi: 10.1016/S0140-6736(25)01153-5

Atrial FibrillationHeart, Artery and Coronary Diseases

Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial

JAMA Cardiol

Yamaguchi J, Arashi H, Hagiwara N, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Matsui K, Ogawa H, AFIRE Investigators

doi: 10.1001/jamacardio.2025.2611

Related content

Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry

Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III

Long-Term Effects of Catheter Ablation vs Medical Therapy in Patients with Atrial Fibrillation and Heart Failure: A Reconstructed Individual Patient Data Meta-Analysis

Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Risk of syncope and permanent pacing with rate versus rhythm control of atrial fibrillation: A systematic review and meta-analysis

Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial

Safety and efficacy of steroidal mineralocorticoid receptor antagonists in patients with kidney failure requiring dialysis: a systematic review and meta-analysis of randomised controlled trials

Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial